TWO SIGMA ADVISERS, LP - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$76,000
-69.1%
36,200
-57.5%
0.00%
-100.0%
Q1 2021$246,000
+161.7%
85,200
+94.5%
0.00%
Q4 2020$94,000
-10.5%
43,800
+159.2%
0.00%
Q3 2020$105,00016,9000.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Eversept Partners, LP 522,042$1,117,1700.13%
XTX MARKETS LLC 26,041$56,0000.12%
Samsara BioCapital, LLC 300,000$642,0000.06%
Ikarian Capital, LLC 650,000$1,392,0000.06%
Opaleye Management Inc. 187,750$402,0000.05%
SABBY MANAGEMENT, LLC 108,026$231,0000.04%
Anson Funds Management LP 97,601$209,0000.04%
Virtu Financial LLC 83,221$178,0000.02%
GSA CAPITAL PARTNERS LLP 47,084$101,0000.02%
WEXFORD CAPITAL LP 19,512$42,0000.01%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders